Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
34
ALLO Quote, Financials, Valuation and Earnings
Last price:
$1.24
Seasonality move
:
-16.36%
Day range:
$1.21 - $1.29
52-week range:
$0.86 - $3.78
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2,916.87x
P/B ratio:
0.70x
Volume:
2.2M
Avg. volume:
2.9M
1-year change:
-64.86%
Market cap:
$269M
Revenue:
$22K
EPS (TTM):
-$1.23
Earnings Data
Next earnings date for ALLO
Aug 07
2025
Most recent earnings per share
-$0.28
Beat by $0.02
(May 13/2025)
Consensus Estimate
-$0.30
(May 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ALLO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.24 | -- |
| 08/07/2025 | Q2 | -- | -- | -- | -$0.26 | -- |
| 05/13/2025 | Q1 | $1.7K | -- | -$0.28 | -$0.30 | $0.02 |
| 03/13/2025 | Q4 | $12K | -- | -$0.28 | -$0.32 | $0.04 |
| 11/07/2024 | Q3 | $10.7K | -- | -$0.32 | -$0.33 | $0.01 |
| 08/07/2024 | Q2 | $893.9K | -- | -$0.35 | -$0.35 | -$0.00 |
| 05/13/2024 | Q1 | $10.4K | $22K | -$0.38 | -$0.41 | $0.03 |
| 03/14/2024 | Q4 | $22.4K | $21K | -$0.51 | -$0.44 | -$0.07 |
| 11/02/2023 | Q3 | -- | -- | -$0.37 | -$0.52 | $0.15 |
| 08/02/2023 | Q2 | -- | -- | -$0.53 | -$0.59 | $0.06 |
| 05/03/2023 | Q1 | -- | -- | -$0.68 | -$0.62 | -$0.06 |
| 02/28/2023 | Q4 | -- | -- | -$0.66 | -$0.69 | $0.03 |
| 11/02/2022 | Q3 | -- | -- | -$0.58 | -$0.65 | $0.07 |
| 08/09/2022 | Q2 | -- | -- | -$0.52 | -$0.61 | $0.09 |
| 05/04/2022 | Q1 | -- | -- | -$0.56 | -$0.58 | $0.02 |
| 02/23/2022 | Q4 | -- | -- | -$0.54 | -$0.59 | $0.05 |
| 11/04/2021 | Q3 | -- | -- | -$0.57 | -$0.56 | -$0.01 |
| 08/04/2021 | Q2 | -- | -- | -$0.53 | -$0.54 | $0.01 |
| 05/05/2021 | Q1 | -- | -- | -$0.25 | -$0.40 | $0.15 |
| 02/25/2021 | Q4 | -- | -- | -$0.53 | -$0.55 | $0.02 |
| 11/04/2020 | Q3 | -- | -- | -$0.52 | -$0.55 | $0.03 |
| 08/05/2020 | Q2 | -- | -- | -$0.53 | -$0.54 | $0.01 |
| 05/06/2020 | Q1 | -- | -- | -$0.50 | -$0.58 | $0.08 |
| 02/27/2020 | Q4 | -- | -- | -$0.58 | -$0.68 | $0.10 |
| 11/05/2019 | Q3 | -- | -- | -$0.50 | -$0.54 | $0.04 |
| 08/07/2019 | Q2 | -- | -- | -$0.41 | -$0.44 | $0.03 |
| 05/07/2019 | Q1 | -- | -- | -$0.32 | -$0.44 | $0.12 |
| 03/08/2019 | Q4 | -- | -- | -$0.37 | -$0.25 | -$0.12 |
| 11/21/2018 | Q3 | -- | -- | -$0.43 | -$0.39 | -$0.04 |
Allogene Therapeutics Earnings Questions
-
How Much did Allogene Therapeutics Generate in Revenue Last Quarter?
Allogene Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Allogene Therapeutics Beat Earnings Last Quarter?
Allogene Therapeutics announced earnings per share of -$0.28 which represents a beat of analyst forecast a -$0.30 per share.
-
Is Allogene Therapeutics Profitable?
Allogene Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Allogene Therapeutics EPS Next Year?
Allogene Therapeutics's earnings are forecast to decrease from -$1.32 per share to -$1.32 per share next year representing a decrease of -23.71%.
-
When is Allogene Therapeutics's Earnings Date?
Allogene Therapeutics's next earnings date is August 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
